SMTL ID : 4crc.1

Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x OTM: (2S)-2-[[(E)-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-3-phenyl-N-[4-(1H-1,2,3,4-tetrazol-5-yl)phenyl]propanamide(Non-covalent)

OTM.1: 22 residues within 4Å: Chain A: L.28, C.29, H.44, C.45, Y.134, I.141, D.182, A.183, C.184, K.185, G.186, D.187, S.188, T.206, S.207, W.208, G.209, G.211, C.212, G.219, V.220, Y.221 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:L.28, A:I.141, A:K.185, A:T.206 Hydrogen bonds: A:Y.134, A:K.185, A:G.186, A:D.187, A:S.188, A:S.188, A:G.211 Water bridges: A:R.26, A:R.26, A:L.28, A:H.44, A:I.141, A:I.141, A:S.188, A:G.209

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 2 residues within 4Å: Chain A: K.117, R.120 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.117, A:R.120

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fjellstrom, O. et al., Creating Novel Activated Factor Xi Inhibitors Through Fragment Based Lead Generation and Structure Aided Drug Design. Plos One (2015)

Release Date

2015-02-11

Peptides

COAGULATION FACTOR XI: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

COAGULATION FACTOR XI

Related Entries With Identical Sequence